1Reus AD, van Besouw NM, Molenaar NM, et al. An immunologi- cal basis for chronic histiocytic intervillositis in recurrent fetal lass [J]. Am JReprod Immunol, 2013, 70(3) : 230 -237.
2Mosaferi E, Majidi J, Mohammadian M, et al. HLA - G expression pattern : reliable assessment for pregnancy outcome prediction [ J ]. Ady Pharm Bull, 2013, 3(2) : 443 -446.
3Inada K, Shima T, Nakashima A, et. al. Characterization of regula- tory T cells in decidua of miscarriage cases with abnormal or normal fetal chromosomal content[ J ]. J Reprod I mmunol, 2013, 97 (1) : 104 -111.
4Szekers - Bartho J. Progesterone - mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage [ J ]. Immunotherapy, 2009, 1 (5) : 873 - 882.
5Kheshtehin N, GharagoMoo M, Andalib A, et al. The expression of Thl - and Th2 - related chemokine receptors in women with recur- rent miscarriage: the impact of lymphocyte immunotherapy[ J]. Am J Reorod Immunol. 2010.64(2) : 104 -112.
